CNTB

NASD Connect Biopharma Holdings Ltd.
Oct 8, 2026 · 7:02 AM ET LAST TRADE Market Closed

$0.9400 ↓ -0.0047 (-0.50%) Trading Down from the previous close of $0.9447

YTD change
-66.67%
vs 20-day SMA
-23.00%
vs 200-day SMA
-59.63%

Price ranges

Previous day
$0.8900 $0.9689
open $0.9000 close $0.9447
+$0.0447 (+4.97%)
Today
$0.0000 $0.0000
$0.9400
Past week
$0.8501 $1.1200
from $1.1000 now $0.9400
-$0.1600 (-14.55%)
Past month
$0.8501 $2.0991
from $2.0100 now $0.9400
-$1.0700 (-53.23%)
This year
$0.8501 $3.8200
from $2.8200 now $0.9400
-$1.8800 (-66.67%)

Price & Performance

-1.69 (-64.08%) / 6M

$0.7257$1.56$2.39$3.22Apr 8Jul 9Oct 7

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 96.8% away from all-time highs of $29.2735
  • CNTB is down 67% since the beginning of the year
  • CNTB is down 48% over the past 12 months
  • CNTB is down 53% over the past 1 month
  • 14% of all CNTB investors are betting against CNTB

CNTB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -48.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.27
Earnings momentum -4.4% Quarterly EPS growth
Quarterly change -4.4%

Valuation

P/E ratio N/A
Enterprise value $28.5M
Beta -0.15

Balance sheet & scale

IncomeN/A
Revenue$3.0M
Cash$31.5M
Debt$596.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $59.2M

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $413.08 +2.60%
MRNA Moderna, Inc. $196.48 +4.81%
RVMD Revolution Medicines, Inc. $200.87 +0.50%
ROIV Roivant Sciences Ltd. $34.75 -2.20%
BNTX BioNTech SE Sponsored ADR $95.25 -0.50%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.